You are here

  • Home
  • Archive
  • Volume 70, Issue 9
  • EGFR amplification and outcome in a randomised phase III trial of chemotherapy alone or chemotherapy plus panitumumab for advanced gastro-oesophageal cancers

Article metrics

Article menu
XML
Upper GI cancer
Original research
EGFR amplification and outcome in a randomised phase III trial of chemotherapy alone or chemotherapy plus panitumumab for advanced gastro-oesophageal cancers

 

Online download statistics by month:

Online download statistics by month: November 2020 to March 2024

AbstractFullPdf
Nov 2020646633298
Dec 2020396394124
Jan 202120818669
Feb 202114810864
Mar 202119814176
Apr 202116411274
May 202114814946
Jun 202114013870
Jul 202115315345
Aug 2021563568172
Sep 2021297279109
Oct 2021355349113
Nov 202115914285
Dec 202121621051
Jan 2022179171112
Feb 202215315957
Mar 202221221980
Apr 2022219213111
May 2022253254106
Jun 202220020295
Jul 202217716868
Aug 202219218895
Sep 2022204204130
Oct 202216917369
Nov 202216816054
Dec 202213312746
Jan 202313812237
Feb 202316616454
Mar 202320719656
Apr 202314314159
May 202312811943
Jun 202317117174
Jul 202318217975
Aug 202315314958
Sep 202310310331
Oct 202315014149
Nov 202312411537
Dec 202313012051
Jan 2024836239
Feb 2024898638
Mar 2024121116128
Total813877843248